Sexually Transmitted Diseases (STD) Testing Market Analysis Size Growth Insights and Research Report 2023 - 2030

Sexually Transmitted Diseases (STD) Testing Market Size, Industry Share, Trends, Growth Outlook and Forecast 2023 - 2030

<h2>Global Sexually Transmitted Diseases Testing Market is segmented By Device Type (Thermal Cyclers, Lateral Flow Readers, Flow Cytometers, Differential Light Scattering Machines, Others), By Disease Type (Chlamydia, Syphilis), By Application (Laboratory Testing, Point of Care Testing), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

&nbsp;

<h2>Sexually Transmitted Diseases Testing Market Overview</h2>

<blockquote>
The Global Sexually Transmitted Diseases (STD) Testing Market is expected to grow at a <a href="https://www.datamintelligence.com/download-sample/sexually-transmitted-diseases-testing-market">CAGR of 11.54%</a> during the forecast&nbsp;period (2023-2030).
</blockquote>

&nbsp;

<h2>Sexually Transmitted Diseases Testing Market Scope and Summary</h2>

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			11.54%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Type,&nbsp;By Function,&nbsp;By End-User Industry, and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

To Get a Free Sample&nbsp;<a href="https://www.datamintelligence.com/download-sample/sexually-transmitted-diseases-testing-market">Click here</a>

&nbsp;

Why Purchase the Report?

Visualize the composition of the Global Sexually Transmitted Diseases (STD) Testing Market in terms of various types of drug class, formulation type, and end-users highlighting the critical commercial assets and players.

Identify commercial opportunities in global Sexually Transmitted Diseases (STD) Testing Market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global Sexually Transmitted Diseases (STD) Testing Market-level 4/5 segmentation.

A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

&nbsp;

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

<a href="https://www.datamintelligence.com/enquiry/sexually-transmitted-diseases-testing-market">Education &amp; Research Institutes</a>

Research Professionals

Emerging Companies

Manufacturers

&nbsp;

<h2>Trending Topics</h2>

<a href="https://www.datamintelligence.com/research-report/baby-cleaning-products-market">Baby Cleaning Products Market</a>

<a href="https://www.datamintelligence.com/research-report/radiation-therapy-equipment-market">Radiation Therapy Equipment Market</a>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>
		Market Snippet by Device Type
		</li>
		<li>
		Market Snippet by Disease Type
		</li>
		<li>
		Market Snippet by Application
		</li>
		<li>
		Market Snippet by Region
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Growing sexually transmitted diseases
				</li>
				<li>
				Reimbursement policies
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				Inadequate Diagnosis Facilities
				</li>
			</ol>
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Supply Chain Analysis
		</li>
		<li>
		Pricing Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Epidemiology Analysis
		</li>
	</ol>
	</li>
	<li>
	<h3>By Device Type</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
			</li>
			<li>
			Market Attractiveness Index, By Device Type
			</li>
		</ol>
		</li>
		<li>
		Thermal Cyclers

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2028
			</li>
		</ol>
		</li>
		<li>
		Lateral Flow Readers
		</li>
		<li>
		Flow Cytometers
		</li>
		<li>
		Differential Light Scattering Machines
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	<h3>By Disease Type</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
			</li>
			<li>
			Market Attractiveness Index, By Disease Type
			</li>
		</ol>
		</li>
		<li>
		Chlamydia

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2028
			</li>
		</ol>
		</li>
		<li>
		Syphilis

		<ol>
			<li>
			Gonorrhea
			</li>
			<li>
			Human Immunodeficiency Virus/AIDS
			</li>
			<li>
			Trichomoniasis
			</li>
			<li>
			Others
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By Application</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Attractiveness Index, By Application
			</li>
		</ol>
		</li>
		<li>
		Laboratory Testing

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2028
			</li>
		</ol>
		</li>
		<li>
		Point of Care Testing
		</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				The U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				The U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East &amp; Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor Sexually Transmitted Diseases (STD) Testing Strategy Analysis
		</li>
		<li>
		Comparative Product Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	<h3>- Company Profiles</h3>

	<ol>
		<li>
		Roche Diagnostics

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Bio-Rad Laboratories
		</li>
		<li>
		Hologic, Inc.
		</li>
		<li>
		Merck and Company Inc
		</li>
		<li>
		Becton Dickinson &amp; Company
		</li>
		<li>
		Cepheid, Inc.
		</li>
		<li>
		Danaher Corporation
		</li>
		<li>
		Affymetrix, Inc.
		</li>
		<li>
		Alere, Inc.
		</li>
		<li>
		Abbott Laboratories
		</li>
	</ol>
	</li>
	<li>
	<h3>Premium Insights</h3>
	</li>
	<li>
	<h3>DataM</h3>

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2>List of Tables and Figures</h2>

LIST OF TABLES

TABLE 01.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE, 2021, 2025 &amp; 2029 , BY DEVICE TYPE, ($MILLION)

TABLE 02.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE 2021, 2025 &amp; 2029 , BY APPLICATION, ($MILLION)

TABLE 03.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE 2021, 2025 &amp; 2029 , BY DISEASE TYPE, ($MILLION)

TABLE 04.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE 2021, 2025 &amp; 2029 , BY REGION, ($MILLION)

TABLE 05.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE 2021, 2025 &amp; 2029 (%), BY DEVICE TYPE ($MILLION)

TABLE 06.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DEVICE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 07.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE 2021, 2025 &amp; 2029 (%), BY APPLICATION ($MILLION)

TABLE 08.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY APPICATION, 2021&ndash;2029 ($MILLION)

TABLE 09.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE 2021, 2025 &amp; 2029 (%), BY DISEASE TYPE ($MILLION)

TABLE 10.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 11.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE 2021, 2025 &amp; 2029 (%), BY REGION ($MILLION)

TABLE 12.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY REGION, 2021&ndash;2029 ($MILLION)

TABLE 13.&nbsp;&nbsp; &nbsp;NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DEVICE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 14.&nbsp;&nbsp; &nbsp;NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 15.&nbsp;&nbsp; &nbsp;NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 16.&nbsp;&nbsp; &nbsp;NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 17.&nbsp;&nbsp; &nbsp;SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DEVICE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 18.&nbsp;&nbsp; &nbsp;SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 19.&nbsp;&nbsp; &nbsp;SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 20.&nbsp;&nbsp; &nbsp;SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 21.&nbsp;&nbsp; &nbsp;EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DEVICE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 22.&nbsp;&nbsp; &nbsp;EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 23.&nbsp;&nbsp; &nbsp;EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 24.&nbsp;&nbsp; &nbsp;EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 25.&nbsp;&nbsp; &nbsp;ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DEVICE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 26.&nbsp;&nbsp; &nbsp;ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 27.&nbsp;&nbsp; &nbsp;ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 28.&nbsp;&nbsp; &nbsp;ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY COUNTRY, 2021&ndash;2029 ($MILLION)

TABLE 29.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DEVICE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 30.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY APPLICATION, 2021&ndash;2029 ($MILLION)

TABLE 31.&nbsp;&nbsp; &nbsp;MIDDLE EAST &amp; AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

TABLE 32.&nbsp;&nbsp; &nbsp;ROCHE DIAGNOSTICS: OVERVIEW

TABLE 33.&nbsp;&nbsp; &nbsp;ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO

TABLE 34.&nbsp;&nbsp; &nbsp;ROCHE DIAGNOSTICS: KEY DEVELOPMENTS

TABLE 35.&nbsp;&nbsp; &nbsp;BIO-RAD LABORATORIES: OVERVIEW

TABLE 36.&nbsp;&nbsp; &nbsp;BIO-RAD LABORATORIES: PRODUCT PORTFOLIO

TABLE 37.&nbsp;&nbsp; &nbsp;BIO-RAD LABORATORIES: KEY DEVELOPMENTS

TABLE 38.&nbsp;&nbsp; &nbsp;HOLOGIC, INC: OVERVIEW

TABLE 39.&nbsp;&nbsp; &nbsp;HOLOGIC, INC: PRODUCT PORTFOLIO

TABLE 40.&nbsp;&nbsp; &nbsp;HOLOGIC, INC: KEY DEVELOPMENTS

TABLE 41.&nbsp;&nbsp; &nbsp;MERCK AND COMPANY INC: OVERVIEW

TABLE 42.&nbsp;&nbsp; &nbsp;MERCK AND COMPANY INC: PRODUCT PORTFOLIO

TABLE 43.&nbsp;&nbsp; &nbsp;MERCK AND COMPANY INC: KEY DEVELOPMENTS

TABLE 44.&nbsp;&nbsp; &nbsp;BECTON DICKINSON &amp; COMPANY: OVERVIEW

TABLE 45.&nbsp;&nbsp; &nbsp;BECTON DICKINSON &amp; COMPANY: PRODUCT PORTFOLIO

TABLE 46.&nbsp;&nbsp; &nbsp;BECTON DICKINSON &amp; COMPANY: KEY DEVELOPMENTS

TABLE 47.&nbsp;&nbsp; &nbsp;CEPHEID, INC: OVERVIEW

TABLE 48.&nbsp;&nbsp; &nbsp;CEPHEID, INC: PRODUCT PORTFOLIO

TABLE 49.&nbsp;&nbsp; &nbsp;CEPHEID, INC: KEY DEVELOPMENTS

TABLE 50.&nbsp;&nbsp; &nbsp;DANAHER CORPORATION.: OVERVIEW

TABLE 51.&nbsp;&nbsp; &nbsp;DANAHER CORPORATION.: PRODUCT PORTFOLIO

TABLE 52.&nbsp;&nbsp; &nbsp;DANAHER CORPORATION.: KG: KEY DEVELOPMENTS

TABLE 53.&nbsp;&nbsp; &nbsp;AFFYMETRIX, INC.: OVERVIEW

TABLE 54.&nbsp;&nbsp; &nbsp;AFFYMETRIX, INC.: PRODUCT PORTFOLIO

TABLE 55.&nbsp;&nbsp; &nbsp;AFFYMETRIX, INC.: KEY DEVELOPMENTS

TABLE 56.&nbsp;&nbsp; &nbsp;ALERE, INC: OVERVIEW

TABLE 57.&nbsp;&nbsp; &nbsp;ALERE, INC: PRODUCT PORTFOLIO

TABLE 58.&nbsp;&nbsp; &nbsp;ALERE, INC: KEY DEVELOPMENTS

TABLE 59.&nbsp;&nbsp; &nbsp;ABBOTT LABORATORIES: OVERVIEW

TABLE 60.&nbsp;&nbsp; &nbsp;ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 61.&nbsp;&nbsp; &nbsp;ABBOTT LABORATORIES: KEY DEVELOPMENTS

&nbsp;LIST OF FIGURES

FIGURE 01.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE, 2021 &amp; 2029 (%), BY DEVICE TYPE

FIGURE 02.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE, 2021 &amp; 2029 (%), BY APPLICATION

FIGURE 03.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE, 2021 &amp; 2029 (%), BY DISEASE TYPE

FIGURE 04.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE, 2021 &amp; 2029 (%), BY REGION

FIGURE 05.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE, 2021 - 2029 AND YEAR ON YEAR GROWTH

FIGURE 06.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY DEVICE TYPE

FIGURE 07&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE, BY THERMAL CYCLERS, 2021&ndash;2029 ($MILLION)

FIGURE 08&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE, BY LATERAL FLOW READERS, 2021&ndash;2029 ($MILLION)

FIGURE 09&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY FLOW CYTOMETERS, 2021&ndash;2029 ($MILLION)

FIGURE 10&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY DIFFERENTIAL LIGHT SCATTERING MACHINES, 2021&ndash;2029 ($MILLION)

FIGURE 11&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY OTHERS, 2021&ndash;2029 ($MILLION)

FIGURE 12.&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY APPLICATION

FIGURE 13&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY LABORATORY TESTING, 2021&ndash;2029 ($MILLION)

FIGURE 14&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY POINT OF CARE TESTING, 2021&ndash;2029 ($MILLION)

FIGURE 15&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY DISEASE TYPE

FIGURE 16&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY CHLAMYDIA, 2021&ndash;2029 ($MILLION)

FIGURE 17&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY GONORRHEA, 2021&ndash;2029 ($MILLION)

FIGURE 18&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY SYPHILIS, 2021&ndash;2029 ($MILLION)

FIGURE 19&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY HUMAN IMMUNODEFICIENCY VIRUS/AIDS, 2021 &amp; 2029

FIGURE 20&nbsp;&nbsp;&nbsp;&nbsp; GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY TRICHOMONIASIS, 2021 &amp; 2029

FIGURE 21 &nbsp;&nbsp;&nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , BY OTHERS, 2021&ndash;2029 ($MILLION)

FIGURE 22&nbsp;&nbsp; &nbsp;GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET YEAR ON YEAR GROWTH 2021 TO 2029 (%), BY REGION

FIGURE 23&nbsp;&nbsp;&nbsp;&nbsp; NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 24&nbsp;&nbsp;&nbsp;&nbsp; NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY PRODUCT DEVICE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 25&nbsp;&nbsp;&nbsp;&nbsp; NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 26&nbsp;&nbsp;&nbsp;&nbsp; NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 27&nbsp;&nbsp;&nbsp;&nbsp; NORTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 28&nbsp;&nbsp;&nbsp; SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 29&nbsp;&nbsp;&nbsp;&nbsp; SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY PRODUCT DEVICE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 30&nbsp;&nbsp; SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 31&nbsp;&nbsp;&nbsp;&nbsp; SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 32&nbsp;&nbsp;&nbsp;&nbsp; SOUTH AMERICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 33&nbsp;&nbsp;&nbsp;&nbsp; EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 34&nbsp;&nbsp; EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY PRODUCT DEVICE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 35&nbsp;&nbsp;&nbsp;&nbsp; EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 36&nbsp;&nbsp; EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 37&nbsp;&nbsp;&nbsp; EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 38&nbsp;&nbsp;&nbsp;&nbsp; ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 39&nbsp;&nbsp;&nbsp;&nbsp; ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY PRODUCT DEVICE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 40&nbsp;&nbsp; &nbsp;ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 41&nbsp;&nbsp;&nbsp;&nbsp; ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 42&nbsp;&nbsp;&nbsp;&nbsp; ASIA PACIFIC SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY COUNTRIES, 2021&ndash;2029 ($MILLION)

FIGURE 43&nbsp;&nbsp;&nbsp; MIDDLE EAST AND AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET VALUE , 2021&ndash;2029 ($MILLION)

FIGURE 44&nbsp;&nbsp;&nbsp;&nbsp; MIDDLE EAST AND AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY PRODUCT DEVICE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 45&nbsp;&nbsp;&nbsp;&nbsp; MIDDLE EAST AND AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY APPLICATION, 2021&ndash;2029 ($MILLION)

FIGURE 46&nbsp;&nbsp;&nbsp;&nbsp; MIDDLE EAST AND AFRICA SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET SHARE (%), BY DISEASE TYPE, 2021&ndash;2029 ($MILLION)

FIGURE 47.&nbsp;&nbsp; &nbsp;ROCHE DIAGNOSTICS: FINANCIALS

FIGURE 48.&nbsp;&nbsp; &nbsp;BIO-RAD LABORATORIES: FINANCIALS

FIGURE 49.&nbsp;&nbsp; &nbsp;HOLOGIC, INC: FINANCIALS

FIGURE 50&nbsp; &nbsp;ALERE, INC: FINANCIALS

FIGURE 51.&nbsp;&nbsp; &nbsp;BECTON DICKINSON &amp; COMPANY: FINANCIALS

FIGURE 52.&nbsp;&nbsp; &nbsp;CEPHEID, INC: FINANCIALS

FIGURE 53.&nbsp;&nbsp; &nbsp; DANAHER CORPORATION.: FINANCIALS

FIGURE 54.&nbsp;&nbsp; &nbsp;AFFYMETRIX, INC.: FINANCIALS

FIGURE 55.&nbsp;&nbsp; &nbsp;MERCK AND COMPANY INC.: FINANCIALS

FIGURE 56.&nbsp;&nbsp; &nbsp;ABBOTT LABORATORIES: FINANCIALS

Metrics	Details
Market CAGR	11.54%
Segments Covered	By Type, By Function, By End-User Industry, and By Region
Report Insights Covered	Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
Fastest Growing Region	Asia Pacific
Largest Market Share	North America